Skip to main content
. Author manuscript; available in PMC: 2015 Jul 2.
Published in final edited form as: JAMA Psychiatry. 2014 May;71(5):547–556. doi: 10.1001/jamapsychiatry.2013.4546

Table 2.

Outcome Variable Findings at Follow-up

Characteristic TAU (n = 95) RP (n = 88) MBRP (n = 103)
Sample size % completed, No. (%)
 3 mo 82 (86.3) 80 (90.9) 95 (92.2)
 6 mo 77 (81.1) 75 (85.2) 89 (86.4)
 12 mo 76 (80.0) 72 (81.8) 83 (80.6)
Drug use days, TLFB, mean (SD)
 3 mo 5.23 (15.43) 2.09 (10.65) 3.92 (16.24)
 6 mo 5.81 (19.11) 1.71 (10.77) 2.73 (12.00)
 12 mo 4.63 (16.03) 6.09 (19.05) 3.06 (15.08)
Any drug use, TLFB, No. (%)
 3 mo 20 (21.0) 11 (12.5) 14 (13.6)
 6 mo 20 (21.0) 7 (8.0) 10 (9.7)
 12 mo 13 (13.7) 15 (17.0) 9 (8.7)
Heavy drinking days, TLFB, mean (SD)
 3 mo 2.64 (10.64) 2.13 (7.75) 1.99 (8.06)
 6 mo 2.61 (9.93) 1.13 (5.96) 1.63 (8.53)
 12 mo 4.65 (14.93) 3.89 (12.17) 1.44 (7.66)
Any heavy drinking, TLFB, No. (%)
 3 mo 19 (20.0) 18 (20.5) 12 (11.7)
 6 mo 15 (15.8) 8 (9.1) 8 (7.8)
 12 mo 19 (20.0) 17 (19.3) 8 (7.8)

Abbreviations: MBRP, mindfulness-based relapse prevention; RP, relapse prevention; TAU, treatment as usual; TLFB, Timeline Follow-back.